ArticleClinical epigenetics2023

A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma.

Jake Shortt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.